Focal Epilepsy Clinical Trial
— PPOfficial title:
Cortical Excitability Assessment of Pharmacoresistant Focal Epilepsy Using Direct Electrical Stimulation During Stereo-electroencephalography
The identification of the epileptogenic zone (EZ) during pharmacoresistant focal epilepsy
presurgical assessment frequently requires intracranial recordings like
stereo-electroencephalography (SEEG). Cortical direct electrical stimulation (DES) is
commonly used during SEEG for functional mapping or to induce seizure.
However, the recording of seizures is sometimes insufficient to circumscribe the EZ and
development of new biomarkers is necessary.
The cortex within the EZ is thought to be hyperexcitable. The "paired pulses" paradigm, using
transcranial magnetic stimulation (TMS), allows determining the hemispheric cortical
excitability level. The investigators hypothesize that paired pulses DES during SEEG could
provide useful information for EZ identification.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | September 30, 2021 |
Est. primary completion date | September 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age above 18 years old - Pharmacoresistant focal epilepsy patients undergoing a stereo-electroencephalographic recording - Provide written consent to the study after receiving clear information - Be a beneficiary or member of health insurance plan Exclusion Criteria: Patient with contraindication for MRI scanning - Pregnancy - Prohibition on participation in other research, apart from any other non-interventional research |
Country | Name | City | State |
---|---|---|---|
France | Hôpital neurologique de Lyon | Lyon |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Presence of a significant difference between the evoked responses to paired pulses cortical electrical stimulation of epileptogenic zone cortex and of normal cortex | Low frequency single pulse electrical stimulation induces several cortico-cortical electroencephalographic responses: early-physiological and/or late-pathological. We expect different paired pulses modulation of those responses according the excitability level of the stimulated cortex (in terms of latency, amplitude, surface, frequency power) | between Day 7 and 21 (End of the stereoelectroencephalographic recordings) | |
Secondary | Presence of a difference of responses patterns between anatomic regions and/or lesion type | between Day 7 and 21 (End of the stereoelectroencephalographic recordings ) | ||
Secondary | Presence of a difference between transcranial magnetic paired pulses stimulations and intracranial paired pulses cortical direct electrical stimulations | Between Day 7 and 21 (End of the stereoelectroencephalographic recordings) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT05081518 -
A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy
|
Phase 1 | |
Withdrawn |
NCT05481905 -
ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures
|
Phase 2 | |
Completed |
NCT02208492 -
The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study
|
Phase 4 | |
Recruiting |
NCT04839601 -
RNS System RESPONSE Study
|
N/A | |
Completed |
NCT02898935 -
Improvement of the Accuracy of Spatial Representation of Invasive Exploratory Electrodes in Focal Epilepsy
|
||
Enrolling by invitation |
NCT05748236 -
The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy
|
Phase 4 | |
Terminated |
NCT01724918 -
Lacosamide IV and EEG/EKG (LIVE) Study
|
Phase 2 | |
Completed |
NCT00855738 -
A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice
|
Phase 4 | |
Recruiting |
NCT06309966 -
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06210022 -
Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy
|
||
Completed |
NCT01311440 -
Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy
|
N/A | |
Terminated |
NCT03955432 -
Long-term Cardiac Monitoring in Epilepsy
|
N/A | |
Recruiting |
NCT06132893 -
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
|
Phase 2/Phase 3 | |
Recruiting |
NCT05100771 -
Optimized Volumetry in Radiology: Interest in Pediatric Brain MRI in the Exploration of Focal Epilepsy
|
||
Recruiting |
NCT04879433 -
Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy
|
||
Active, not recruiting |
NCT03916848 -
Novel Network Analysis of Intracranial Stereoelectroencephalography
|
N/A | |
Recruiting |
NCT05198882 -
Clinical Evaluation of Interstitial Laser Thermal Therapy Under Continuous MRI Monitoring as a Minimally Invasive Treatment of Patients With Medically Unbalanced Partial Epilepsy
|
Phase 1 | |
Recruiting |
NCT05981755 -
Breathing Rescue for SUDEP Prevention
|
N/A | |
Recruiting |
NCT03457961 -
Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong
|
||
Not yet recruiting |
NCT06443463 -
Long-term Safety and Tolerability of BHV-7000
|
Phase 2 |